Frequently Asked Questions About Infertility

Infertility is defined as the failure to achieve a successful pregnancy despite 12 months or more of unprotected, appropriate, and timely intercourse.

In the diagnostic evaluation of infertile couples, a comprehensive history and physical examination must be conducted.

Approximately 30% of couples have unexplained infertility.

Recurrent pregnancy loss is defined as two or more consecutive pregnancy losses.

Smoking is associated with approximately 13% of the underlying causes of infertility.

Obesity leads to disrupted ovulation and decreased ovarian response, causing infertility.

The most common risk factors for Ovarian Hyperstimulation Syndrome (OHSS) include young age, low weight, polycystic ovary syndrome, a history of OHSS, high-dose gonadotropin use, and high E2 levels.

The most commonly used screening test to evaluate ovarian reserve is FSH measurement.

The standard test for evaluating tubal factors is hysterosalpingography (uterine X-ray).

Improvement in sperm parameters after varicocele treatment occurs as early as 3-6 months.

Clomiphene citrate is the most effective initial treatment option for anovulatory infertility in most women.

If couples under 35 have had unprotected intercourse for one year without conception, or for six months if they are 35 or older, they should be investigated for infertility.

The most common underlying causes of amenorrhea (absence of menstruation or abnormal cessation of menstruation) include polycystic ovary syndrome, hypothalamic causes, ovarian insufficiency, and hyperprolactinemia.

Scientific evidence does not conclusively prove that fertility-enhancing drugs used in infertile patients increase the risk of invasive ovarian, breast, uterine, or thyroid cancers.

Hormonal contraceptive drugs are an effective and reliable reversible contraception method.

Both traditional and modern hormonal contraceptives reduce the risk of both uterine and ovarian cancers.